News

Elevate anterior prolapse repair system is a minimally invasive, single-incision total transvaginal approach for treating cystoceles and vault prolapse. It utilizes minimal blind needle passages and follows proven

The Phase III study is a US multi-center, randomized, controlled trial, in which the efficacy and safety of Trinam will be investigated in patients with end-stage renal disease

To date, the FDA has not approved any product for treating corneal graft rejection. Currently, EyeGate is enrolling two Phase II clinical studies utilizing EGP-437 in uveitis and

Liquidity and Capital Resources As of November 30, 2008, the company working capital deficit of $531,257 was comprised of current assets of $16,073 and current liabilities of $547,330.

Galapagos will be responsible for the discovery and preclinical development of new small molecule candidate drugs based on novel Galapagos targets. Merck will have the exclusive option to

“Our rapid product development capability is an important strategic advantage for Mindray, as it continues to generate new revenue streams in an increasingly price-competitive medical device market,” remarked

“But I like the idea of the American people’s representatives expressing their views on an issue like this,” he said, lauding a “bipartisan” consensus in Congress that such

According to Adhezion Biomedical, FloraSeal is designed to help reduce the incidence of surgical site infections, a healthcare-associated infection. This is the second Adhezion Biomedical product to receive

Over the past 40 years, Mr Des Marais II has served on the board of more than 20 companies, most notably Rothmans, Imperial Oil, Royal Bank of Canada,